- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
InnoCan Pharma Corp (INNO)
InnoCan Pharma Corp stock price live, this page displays CSE INNO stock exchange data. View the INNO premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the InnoCan Pharma Corp real time stock price chart below.
What Is the InnoCan Pharma Corp Stock Price Today?
The InnoCan Pharma Corp stock price today is 6.50.
What Is the Stock Symbol for InnoCan Pharma Corp?
The stock symbol for InnoCan Pharma Corp is "INNO."
What Stock Exchange Does InnoCan Pharma Corp Trade On?
InnoCan Pharma Corp is listed and trades on the CSE stock exchange.
Is InnoCan Pharma Corp a Good Stock to Buy?
Determining whether InnoCan Pharma Corp—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the INNO quote. (ISIN: CA45783P5085)
What Is the InnoCan Pharma Corp Stock Price Today?
The InnoCan Pharma Corp stock price today is 6.50.
What Is the Stock Symbol for InnoCan Pharma Corp?
The stock symbol for InnoCan Pharma Corp is "INNO."
What Stock Exchange Does InnoCan Pharma Corp Trade On?
InnoCan Pharma Corp is listed and trades on the CSE stock exchange.
Is InnoCan Pharma Corp a Good Stock to Buy?
Determining whether InnoCan Pharma Corp—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the INNO quote. (ISIN: CA45783P5085)
6.50
+0.18(+2.85%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
6.40
6.50
52 wk Range
5.76
21.00
INNO is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
6.406.50
52 wk Range
5.7621.00
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
INNO Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Neutral
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Impressive gross profit margins
InnoCan Pharma Corporation operates as a pharmaceutical technology company in United States, Canada, Europe, and internationally. The company operates through two segments: Pharmaceuticals and Consumer Wellness. The company's Pharmaceutical segment engages in the development of drug delivery technologies for both human and animal health applications, based on advanced cannabinoids science. It offers a Cannabidiol-loaded Liposome injection Platform (LPT-CBD) that facilitates dosing and release of synthetic cannabidiol into the blood stream for the treatment of chronic pain. The company's Consumer Wellness segment engages in the development and marketing of self-care and hemp-derived cannabidiol beauty products through the brand B.I. Sky. Skincare and Beauty: Its skincare product range includes face creams, serums, masks, soaps, and neck creams for the treatment of dark spot, skin discoloration, hyperpigmentation, and anti-aging . Its pain relief products includes cannabidiol-based topical treatments, such as pain relief sprays and roll-on formulations. InnoCan Pharma Corporation was founded in 2017 and is headquartered in Calgary, Canada.
InnoCan Pharma Corp Earnings Call Summary for Q3/2025
- InnoCan Pharma reported a 90.8% gross margin in its wellness division despite a stock decline of 4.76% to $0.24 following Q3 2025 earnings call
- Company is advancing its LPT/CBD product through a 505(b)(2) FDA pathway, targeting human trials within 18 months and potential treatment for 3.5 million dogs
- Strategic focus on chronic pain management (20% of US citizens) and veterinary markets, with projected market values of $1.9B and $2.2B respectively
- Revenue decreased (specific figures undisclosed) while maintaining product diversity with over 75 offerings on Amazon
- U.S. public offering plans delayed due to SEC issues despite potential $1B revenue opportunity from the veterinary market
Last Updated: 2025-11-27, 01:38 p/m
Read Full TranscriptCompare INNO to Peers and Sector
Metrics to compare | INNO | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipINNOPeersSector | |
|---|---|---|---|---|
P/E Ratio | −19.0x | −2.2x | −0.4x | |
PEG Ratio | −0.46 | 0.03 | 0.00 | |
Price/Book | 3.8x | 1.2x | 2.6x | |
Price / LTM Sales | 0.8x | 1.9x | 3.2x | |
Upside (Analyst Target) | - | 56.4% | 46.7% | |
Fair Value Upside | Unlock | 10.4% | 7.6% | Unlock |
Earnings
Latest Release
Mar 30, 2026
EPS / Forecast
0.45 / --
Revenue / Forecast
4.99M / --
FAQ
What Is the InnoCan Pharma (INNO) Stock Price Today?
The InnoCan Pharma stock price today is 6.50 CAD.
What Stock Exchange Does InnoCan Pharma Trade On?
InnoCan Pharma is listed and trades on the Canadian Securities Exchange.
What Is the Stock Symbol for InnoCan Pharma?
The stock symbol for InnoCan Pharma is "INNO."
What Is the InnoCan Pharma Market Cap?
As of today, InnoCan Pharma market cap is 29.24M CAD.
What Is InnoCan Pharma's Earnings Per Share (TTM)?
The InnoCan Pharma EPS (TTM) is -0.25.
From a Technical Analysis Perspective, Is INNO a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.
How Many Times Has InnoCan Pharma Stock Split?
InnoCan Pharma has split 1 times.
What is the current trading status of InnoCan Pharma (INNO)?
As of Apr 24, 2026, InnoCan Pharma (INNO) is trading at a price of 6.50 CAD, with a previous close of 0.24 CAD. The stock has fluctuated within a day range of 6.40 CAD to 6.50 CAD, while its 52-week range spans from 5.76 CAD to 21.00 CAD.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.